PTOTSLPOtherDevelopmental medicine and child neurology2024

Neurological assessment tool for screening infants during the first year after birth: The Brief-Hammersmith Infant Neurological Examination.

Domenico M Romeo, Chiara Velli, Francesca Sini and 6 others

PMID 38287208

WHAT IT FOUND

A shortened neurological exam for infants detected cerebral palsy with high accuracy in a retrospective study.

Scores below specific age-based cut-offs identified most infants who later developed CP, supporting its use as a quick screening tool to trigger full examination.

Key findings

01The Brief-HINE correctly identified infants with cerebral palsy using age-specific cut-off scores, with sensitivity ranging from 0.88 to 1.00 and specificity from 0.81 to 0.92 across 3 to 12 months.

02More than half of infants who developed CP showed atypical scores on the Brief-HINE as early as 3 months of age.

03The tool is designed to be completed in under 5 minutes, making it feasible for routine screening in busy clinical settings.

STILL TO COME

How it was doneWhat they foundWhat it means for PTsWhat it means for OTsWhat it means for SLPs

Read the rest of this summary

You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.

Already have one?

What it does not show

The study was retrospective, meaning the Brief-HINE scores were derived from existing full-HINE data rather than being applied prospectively in a new clinical setting. There was no sample size calculation performed prior to the study. The tool was only validated against a diagnosis of cerebral palsy, so its utility for identifying other neurological conditions or minor impairments remains unknown. The study was conducted at a single center, which may limit the generalizability of the findings to other clinical populations.

Declared interests

No specific funding or conflict of interest declarations were provided in the text.

The easy way to misread this

Do not use the Brief-HINE as a standalone diagnostic tool for cerebral palsy. It is a screening instrument designed to identify infants who require a more comprehensive full neurological examination. A low score indicates risk, not certainty, and should always be followed by further assessment.

Read it on PubMed →